Sign in
4

Changes in Ownership

TriSalus Life Sciences, Inc. Filed Acc 0001628280-26-035995

Director bought 610,000 shares at $2.50 ($1,525,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stansky Michael P Director 2026-05-15 Purchase +410,000 $2.50 $1,025,000 1,240,722 D
Stansky Michael P Director 2026-05-15 Purchase +200,000 $2.50 $500,000 399,698 I
Open-market purchases · 610,000 sh · avg $2.50 · $1,525,000
Loading xslF345X06/wk-form4_1779136952.xml…